Xu Yaochang, Founder of Abbisko Therapeutics

Xu Yaochang is the founder of Abbisko Therapeutics. Abbisko Therapeutics has raised $28M in total funding. Latest round: Series A. Based in Shanghai, China.

About Xu Yaochang

Yao-Chang Xu is the founder and CEO of Abbisko Therapeutics, a Shanghai-based startup established in 2016. The company focuses on developing immuno-oncology drugs, particularly small-molecule drugs for cancers prevalent in Asian patient populations, and also has early-stage programs in liver disease, viral infections, and CNS disorders. Abbisko Therapeutics successfully raised $28 million in Series A financing to advance its cancer immunotherapies into clinical trials and establish R&D teams and discovery centers. Xu, an industry veteran with 25 years of experience, previously served as general manager at Hansoh BioMedical and held executive roles at Novartis Institutes for BioMedical Research and Eli Lilly.

Xu Yaochang at a glance

More founders in Shanghai, China (28)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades